Publications
5674 Results
- Journal / Conference
- Endocrine-Related Cancer May 9;29(6):335-344
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID35324465
- Study Number(s)
- CTSU/C80701
Everolimus with or without bevacizumab in advanced pNET: CALGB 80701 (Alliance)
- Journal / Conference
- BMC Health Services Research Apr 1;22(1):432
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID35365139
- PMC
- PMC8973954
- Study Number(s)
- S1415CD
Successes and challenges of implementing a cancer care delivery intervention in community oncology practices: lessons learned from SWOG S1415CD
- Journal / Conference
- Clinical Journal of Oncology Nursing Jun 1;26(3):283-292
- Year
- 2022
- Research Committee(s)
- Palliative Care
- PMID
- PMID35604741
- Study Number(s)
- S1820
Altering Intake and Managing Symptoms (AIMS): Feasibility of a Diet Modification Intervention for Post-Treatment Bowel Dysfunction in Rectal Cancer [S1820 Pilot]
- Journal / Conference
- J Clin Oncol 40, 2022 (suppl 16; abstr 6543) poster #326; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
- Year
- 2022
- Research Committee(s)
- Lung
- Study Number(s)
- LUNGMAP
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP)
- Journal / Conference
- J Clin Oncol 40, 2022 (suppl 16; abstr 6505), abst 6505; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL), oral
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
The Medicaid Expansion of the Affordable Care Act and Participation of Patients with Medicaid in SWOG Cancer Clinical Trials
- Journal / Conference
- Prostate
- Year
- 2022
- Research Committee(s)
- Genitourinary
- PMID
- PMID35538398
- PMC
- PMC9839346
- Study Number(s)
- CTSU/E3805
Association between baseline body mass index and survival in men with metastatic hormone-sensitive prostate cancer: ECOG-ACRIN CHAARTED E3805
- Journal / Conference
- Cancer Epidemiology Biomarkers & Prevention May 4;31(5):1077-1089
- Year
- 2022
- Research Committee(s)
- Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID35438744
- PMC
- PMC9081195
- Study Number(s)
- S0000
Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
- Journal / Conference
- J Clin Oncol 40, 2022 (suppl 16; abstr 4522), poster 14; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
- Year
- 2022
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1314
Association of DNA damage response (DDR) gene alterations (alts) and response to neoadjuvant cisplatin-based chemotherapy (chemo) in muscle-invasive bladder cancer (MIBC) patients (pts) enrolled onto SWOG S1314
- Journal / Conference
- J Clin Oncol 40, 2022 (suppl 16; abstr 1518), poster 112; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
- Study Number(s)
- S1415CD
A Pragmatic Cluster-Randomized Trial of a Standing Physician Order Entry Intervention for Colony Stimulating Factor use among Patients at Intermediate Risk for Febrile Neutropenia (SWOG S1415CD)
- Journal / Conference
- J Clin Oncol 40, 2022 (suppl 16; abstr 1525), poster 119; ASCO Annual Meeting (June 3-7, 2022, Chicago, IL)
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
- Study Number(s)
- S1415CD